Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RxSight, Inc. Director's Dealing 2025

Jun 4, 2025

33077_dirs_2025-06-03_b485f0b9-29bd-47fa-9aa6-f2edb54b32ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2025-06-02

Reporting Person: Weinberg Eric (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-06-02 Common Stock M 188002 $3.93 Acquired 195351 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-02 Stock Option (right to buy) $3.93 M 188002 Disposed 2025-07-29 Common Stock (188002) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 299978 Indirect
Common Stock 925 Indirect

Footnotes

F1: Includes 1,121 shares of Common Stock acquired April 30, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.

F2: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee.

F3: Form 3 filed July 29, 2021 incorrectly reflected 187,998 shares.